ImmunityBio, Inc. (IBRX)
IBRXImmunityBio, Inc.loading…
loading…
after-hours · no prints
QTick signal
-5net
1 bull / 4 bear factors · leaningBull 1 pts·Bear 6 pts30d
loading…
Market context—Sector read · not on fileRiskBalance sheet · Distress—Inflation-report days · not on fileRiskFalling sharply · sharp-drop risk 85/100 · was 32 on Nov 5 · Nov 91/6Bottom watch · 1 of 6 confirmations
Golden cross
50-day average is above the 200-day, but price is 18% below the 50-day average — the uptrend is damaged
Momentum (RSI)38.6fires under 35 · fires near $6.44
Price vs. profitno profit to compare
Price vs. its own pastnot on file
Last session traded heavier than its own normal, price down 17.7%. Over the last 20 sessions, 62% of the volume traded on days the stock closed lower.
Entry strategy · 10 triggers
5 of 6 aligned — not yetRSI 14
●
38.6
fires under 35 · fires near $6.44
vs 50-day
✓
$8.72
below the line
Bollinger
✓
$7.23
lower-band pierce
VWAP 20
✓
$8.61
below the rolling VWAP
Entry level
✓
$7.07
within 1% of model level
Put wall
✓
$11.00
2026-11-13 expiry · chain of 2026-11-09
MACD
Context●
-0.11
below zero · still falling
RVolStatic
3.16×
heavier than its own normal
Short int.Static
31.2%
31.2% of float short — crowded
ATRStatic
$0.73
14-session average true range
A checklist, not odds on a return: 4 of 6 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
Next earnings
2026-11-09
reported today · reaction session open
Next dividend
No indicated yield
no forward dividend on file